Super Vilitra is a combination medication that contains two active ingredients: vardenafil and dapoxetine. It is used to treat two common male sexual health issues: erectile dysfunction (ED) and premature ejaculation (PE). Here's how Super Vilitra works and what each of its components does:

Vardenafil (PDE5 Inhibitor):

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor, similar to sildenafil (Viagra) and tadalafil (Cialis). It works by blocking the action of the enzyme PDE5, which is responsible for breaking down cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the penis.

By inhibiting PDE5, Super Vilitra vardenafil allows cGMP levels to increase, leading to relaxation of the smooth muscles and increased blood flow to the penis during sexual stimulation. This mechanism helps men with ED achieve and maintain erections sufficient for sexual activity.

Dapoxetine (SSRI):

Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation (PE). Unlike vardenafil, which primarily targets the physiological aspect of ED, dapoxetine addresses the psychological aspect of PE by modulating serotonin levels in the brain.

Serotonin is a neurotransmitter involved in regulating mood, emotions, and ejaculation. Dapoxetine increases serotonin levels by blocking its reuptake, thereby prolonging the time it takes to ejaculate and improving control over ejaculation.

By combining vardenafil and dapoxetine in Super Vilitra, this medication addresses both ED and PE simultaneously, providing a comprehensive solution for sexual performance issues in men. It helps improve erectile function and delay ejaculation, leading to enhanced sexual satisfaction and a more fulfilling sexual experience.